Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)

被引：0
|
作者：
Martinez-Muniz, Andres E. [1 ]
Sivanand, Sharanya [2 ]
Vander Heiden, Matthew [2 ]
机构：
[1] Univ Puerto Rico Mayaguez, Mayaguez, PR USA
[2] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4358
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Comprehensive genomic analysis in metastatic pancreatic ductal adenocarcinoma (PDAC).
    Wong, Hui-Li
    Jones, Martin
    Eirew, Peter
    Karasinska, Joanna
    Schrader, Kasmintan A.
    Lim, Howard John
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa J.
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [2] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
  • [3] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
  • [4] Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
    Le, Kai
    Wang, Jia
    Zhang, Tao
    Guo, Yifan
    Chang, Hong
    Wang, Siyuan
    Zhu, Bin
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (04): : 422 - 427
  • [5] Pancreatic ductal adenocarcinoma (PDAC) early detection
    Hinestrosa, Juan P.
    Dhani, Harmeet
    Schroeder, Gregor
    Lewis, Jean M.
    Balcer, Heath I.
    Kurzrock, Razelle
    Keith, Dove
    Sears, Rosalie
    Billings, Paul
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
    Chandana, Sreenivasa
    Babiker, Hani M.
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (02) : 161 - 177
  • [7] Comprehensive molecular profiling of paired patient samples of primary and metastatic (met) pancreatic ductal adenocarcinoma (PDAC).
    Trivedi, Neel
    Feldman, Rebecca
    Wang, Hongkun
    Karki, Nabin Raj
    Marshall, John
    Weinberg, Benjamin Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Genomic characterization of ATM alterations in advanced pancreatic ductal adenocarcinoma (PDAC).
    Perera, Sheron
    Denroche, Robert Edward
    Holter, Spring
    Kelly, Deirdre
    Zhang, Amy
    Wang Yifan
    Dodd, Anna
    Ramotar, Stephanie
    Hutchinson, Shawn
    Tehfe, Mustapha
    Ramjeesingh, Ravi
    Biagi, James Joseph
    Wilson, Julie
    Notta, Faiyaz
    Fischer, Sandra
    Zogopoulos, George
    Grant, Robert C.
    Gallinger, Steven
    Knox, Jennifer J.
    O'Kane, Grainne M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [9] Establishment of a metastatic orthotopic model of pancreatic ductal adenocarcinoma (PDAC) for drug development
    Zdrojewska, Justyna
    Maki-Jouppila, Jenni H. E.
    Halleen, Jussi M.
    Bernoulli, Jenni
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Proteome profiling of pancreatic Ductal Adenocarcinoma (PDAC) primary tumors in Caucasian, African Americans and Latinx patients
    Law, Henry C. -H.
    Riner, Andrea N.
    Trevino, Jose G.
    Woods, Nicholas T.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
12345